{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:08:26Z","timestamp":1773850106226,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1016\/s0006-3223(98)00367-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:41:41Z","timestamp":1027629701000},"page":"512-514","source":"Crossref","is-referenced-by-count":146,"title":["A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia"],"prefix":"10.1016","volume":"45","author":[{"given":"Donald C","family":"Goff","sequence":"first","affiliation":[]},{"given":"David C","family":"Henderson","sequence":"additional","affiliation":[]},{"given":"A.Eden","family":"Evins","sequence":"additional","affiliation":[]},{"given":"Edward","family":"Amico","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0006-3223(98)00367-9_BIB1","first-page":"226","article-title":"Clozapine and haloperidol modulate N-methyl-d-aspartate and non-N-methyl-d-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB2","first-page":"787","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB3","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/00001756-199512150-00014","article-title":"Glutamate agonist activity","volume":"6","author":"Banerjee","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0028-3908(91)90161-4","article-title":"Actions of d-cycloserine at the N-methyl-d-aspartate-associated glycine receptor site in vivo","volume":"30","author":"Emmett","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01291892","article-title":"Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics","volume":"104","author":"Evins","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB7","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.15-03-02453.1995","article-title":"Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs","volume":"15","author":"Fitzgerald","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(93)90148-B","article-title":"Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones","volume":"235","author":"Fletcher","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia","volume":"1999 56","author":"Goff","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1176\/ajp.152.8.1213","article-title":"Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia","volume":"152","author":"Goff","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1176\/ajp.153.12.1628","article-title":"d-cycloserine added to clozapine for patients with schizophrenia","volume":"153","author":"Goff","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(97)00079-0","article-title":"Glutamate in schizophrenia","volume":"27","author":"Goff","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB13","first-page":"731","article-title":"Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia","volume":"32","author":"Heresco-Levy","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(96)12834-2","article-title":"Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain","volume":"213","author":"McCoy","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00001756-199801050-00026","article-title":"Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum","volume":"9","author":"Schneider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/S0006-3223(98)00367-9_BIB17","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1523\/JNEUROSCI.14-07-04159.1994","article-title":"Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations","volume":"14","author":"Yamamoto","year":"1994","journal-title":"J Neurosci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322398003679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322398003679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T21:02:41Z","timestamp":1579208561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322398003679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["S0006322398003679"],"URL":"https:\/\/doi.org\/10.1016\/s0006-3223(98)00367-9","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}